Implantable Devices
Nov 03, 2016
Boston Scientific's chief medical officer discusses Watchman, Lotus Edge, and the company's three-pronged bet on bioresorbable scaffold technology. Marie...
Nov 01, 2016
There is still hope for device-based treatments for drug-resistant hypertension. Here, a few of the approaches being pursued and the lessons learned from the...
Nov 01, 2016
Marie Thibault Durability has long been a concern for transcatheter aortic valves (TAVR) since long-term experience with the technology is still limited, at...
Oct 31, 2016
Marie Thibault The Amplatzer PFO Occluder from St. Jude Medical has been approved by FDA to close patent foramen ovale in ischemic stroke patients. St. Jude...
Oct 28, 2016
Marie Thibault St. Jude Medical has paused Nanostim leadless cardiac pacemaker implants. St. Jude Medical has pressed pause on all implants of its Nanostim...
Oct 26, 2016
Marie Thibault CoreValve Evolut R 34 mm transcatheter aortic valve replacement is now the largest FDA-approved valve size. FDA has approved Medtronic's...
Oct 26, 2016
The prospects of TMVR devices rely on careful endpoint measurement and enrollment. David Novotny Transcatheter aortic valve replacement (TAVR) is one of the...
Oct 11, 2016
Marie Thibault The Fortify Assura is among the St. Jude Medical high-voltage devices subject to the advisory. Physicians and patients have been notified about...
Sep 20, 2016
Marie Thibault Boston Scientific's Lotus Edge valve has received CE Mark. Lotus Edge, the next-generation transcatheter aortic valve (TAVR) from Boston...
Sep 19, 2016
Marie Thibault The Gore TAG Thoracic Branch Endoprostheis has FDA Expedited Access Pathway designation and is being studied in a pivotal trial. The Gore TAG...